FDA warning: GranuFlo and NaturaLyte Dialysis Products
The U.S. Food & Drug Administration recently declared a Class I recall of Fresenius Medical Care’s GranuFlo and NaturaLyte dialysis
Read MoreFaulty Pharmaceutical Drugs Resources
The U.S. Food & Drug Administration recently declared a Class I recall of Fresenius Medical Care’s GranuFlo and NaturaLyte dialysis
Read MoreCodeine Use in Certain Children After Tonsillectomy and/or Adenoidectomy: Drug Safety Communication – Risk of Rare, But Life-Threatening Adverse Events
Read MoreThe FDA says there is little evidence that the implants, used to strengthen vaginal tissue, improve pelvic organ prolapse and
Read MoreA new study finds side effects of finasteride may continue months after stopping medication. 96% of subjects’ sexual problems lasted
Read MoreAzithromycin, a macrolide antibiotic, had previously been thought to be relatively free of cardiotoxic effects. In a new review of
Read MoreFDA has completed its review of recent observational (epidemiologic) studies regarding the risk of blood clots in women taking drospirenone-containing
Read MoreMcNeil Consumer Healthcare notified the public of a recall of seven lots (approximately 574,000 bottles) of Infants’ TYLENOL Oral Suspension,
Read MoreThe F.D.A. rejected Qnexa in 2010, amid safety concerns, and the drug’s manufacturer is now presenting additional data to argue
Read MoreThe FDA is warning healthcare professionals and patients about a counterfeit version of Avastin 400mg/16mL, which may have been purchased
Read MorePradaxa (dabigatran etexilate mesylate) is a new blood thinning drug manufactured by Boehringer Ingelheim Pharmaceuticals. Pradaxa is in a class
Read More